Cargando…
The efficacy and safety of Xuebijing injection for corona virus disease 2019: A protocol for a systematic review and meta-analysis
BACKGROUND: Corona virus disease 2019 (COVID-19) is an epidemic respiratory infectious disease caused by Severe Acute Respiratory Syndrome Coronavirus 2 infection. Now it is popular all over the world on a large scale. COVID-19 has the characteristics of rapid transmission, atypical clinical symptom...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7717801/ https://www.ncbi.nlm.nih.gov/pubmed/33285727 http://dx.doi.org/10.1097/MD.0000000000023401 |
_version_ | 1783619374701084672 |
---|---|
author | Fu, Jiaming Wu, Lili Ma, Yingying Liang, Qun |
author_facet | Fu, Jiaming Wu, Lili Ma, Yingying Liang, Qun |
author_sort | Fu, Jiaming |
collection | PubMed |
description | BACKGROUND: Corona virus disease 2019 (COVID-19) is an epidemic respiratory infectious disease caused by Severe Acute Respiratory Syndrome Coronavirus 2 infection. Now it is popular all over the world on a large scale. COVID-19 has the characteristics of rapid transmission, atypical clinical symptoms, easy missed diagnosis and misdiagnosis, and so on. which has seriously affected social and economic development and people's health. Severe acute respiratory syndrome corona virus type 2 infection may lead to systemic cytokine storm, which leads to a sharp deterioration of the condition of ordinary patients. At present, no specific drug has been found in the clinical treatment of covid-19, while Xuebijing injection has been widely used in severe patients in China as a traditional Chinese medicine. The aim of this study is to assess the effificacy and safety of Xuebijing injection for COVID-19. METHODS: Before the research, we conducted a comprehensive search on relevant websites. Two professional researchers will gradually screen, read the title, abstract and full text if necessary, and independently select qualified documents according to the inclusion and exclusion criteria. We will conduct a meta-analysis of the results related to COVID-19 to assess the risks of bias and data extraction. The heterogeneity of data will be studied by Cochrane X(2) and I(2) tests. The evaluation of publication bias will be carried out by funnel chart analysis and Eger test. RESULTS: This review will be disseminated in print by peer-review. CONCLUSION: Our research is to scientifically analyze the clinical evidence of Xuebijing injection in treating severe COVID-19 patients. |
format | Online Article Text |
id | pubmed-7717801 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-77178012020-12-07 The efficacy and safety of Xuebijing injection for corona virus disease 2019: A protocol for a systematic review and meta-analysis Fu, Jiaming Wu, Lili Ma, Yingying Liang, Qun Medicine (Baltimore) 6700 BACKGROUND: Corona virus disease 2019 (COVID-19) is an epidemic respiratory infectious disease caused by Severe Acute Respiratory Syndrome Coronavirus 2 infection. Now it is popular all over the world on a large scale. COVID-19 has the characteristics of rapid transmission, atypical clinical symptoms, easy missed diagnosis and misdiagnosis, and so on. which has seriously affected social and economic development and people's health. Severe acute respiratory syndrome corona virus type 2 infection may lead to systemic cytokine storm, which leads to a sharp deterioration of the condition of ordinary patients. At present, no specific drug has been found in the clinical treatment of covid-19, while Xuebijing injection has been widely used in severe patients in China as a traditional Chinese medicine. The aim of this study is to assess the effificacy and safety of Xuebijing injection for COVID-19. METHODS: Before the research, we conducted a comprehensive search on relevant websites. Two professional researchers will gradually screen, read the title, abstract and full text if necessary, and independently select qualified documents according to the inclusion and exclusion criteria. We will conduct a meta-analysis of the results related to COVID-19 to assess the risks of bias and data extraction. The heterogeneity of data will be studied by Cochrane X(2) and I(2) tests. The evaluation of publication bias will be carried out by funnel chart analysis and Eger test. RESULTS: This review will be disseminated in print by peer-review. CONCLUSION: Our research is to scientifically analyze the clinical evidence of Xuebijing injection in treating severe COVID-19 patients. Lippincott Williams & Wilkins 2020-12-04 /pmc/articles/PMC7717801/ /pubmed/33285727 http://dx.doi.org/10.1097/MD.0000000000023401 Text en Copyright © 2020 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0 |
spellingShingle | 6700 Fu, Jiaming Wu, Lili Ma, Yingying Liang, Qun The efficacy and safety of Xuebijing injection for corona virus disease 2019: A protocol for a systematic review and meta-analysis |
title | The efficacy and safety of Xuebijing injection for corona virus disease 2019: A protocol for a systematic review and meta-analysis |
title_full | The efficacy and safety of Xuebijing injection for corona virus disease 2019: A protocol for a systematic review and meta-analysis |
title_fullStr | The efficacy and safety of Xuebijing injection for corona virus disease 2019: A protocol for a systematic review and meta-analysis |
title_full_unstemmed | The efficacy and safety of Xuebijing injection for corona virus disease 2019: A protocol for a systematic review and meta-analysis |
title_short | The efficacy and safety of Xuebijing injection for corona virus disease 2019: A protocol for a systematic review and meta-analysis |
title_sort | efficacy and safety of xuebijing injection for corona virus disease 2019: a protocol for a systematic review and meta-analysis |
topic | 6700 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7717801/ https://www.ncbi.nlm.nih.gov/pubmed/33285727 http://dx.doi.org/10.1097/MD.0000000000023401 |
work_keys_str_mv | AT fujiaming theefficacyandsafetyofxuebijinginjectionforcoronavirusdisease2019aprotocolforasystematicreviewandmetaanalysis AT wulili theefficacyandsafetyofxuebijinginjectionforcoronavirusdisease2019aprotocolforasystematicreviewandmetaanalysis AT mayingying theefficacyandsafetyofxuebijinginjectionforcoronavirusdisease2019aprotocolforasystematicreviewandmetaanalysis AT liangqun theefficacyandsafetyofxuebijinginjectionforcoronavirusdisease2019aprotocolforasystematicreviewandmetaanalysis AT fujiaming efficacyandsafetyofxuebijinginjectionforcoronavirusdisease2019aprotocolforasystematicreviewandmetaanalysis AT wulili efficacyandsafetyofxuebijinginjectionforcoronavirusdisease2019aprotocolforasystematicreviewandmetaanalysis AT mayingying efficacyandsafetyofxuebijinginjectionforcoronavirusdisease2019aprotocolforasystematicreviewandmetaanalysis AT liangqun efficacyandsafetyofxuebijinginjectionforcoronavirusdisease2019aprotocolforasystematicreviewandmetaanalysis |